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Abstract 
The full-length sequence of KIR2DL5A*001:01:04 differs from that of 
KIR2DL5A*001:01:01 with 8 single intronic nucleotide changes. 
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Natural killer (NK) cells survey the immune system through various receptors 
expressed on their surface. Among these receptors are the killer-cell immunoglobulin-
like receptors (KIR) that have major histocompatibility complex (MHC) I molecules 
serving as their ligands. KIR2DL5 is a two-domain receptor variant and is presumed 
to have inhibitory functions based on the fact that it has immunoreceptor tyrosine-
based inhibitory motifs (ITIMs) on its cytoplasmic tail (1). When the receptor 
recognises self-peptide bound to MHC-I molecules, the cytolytic function of the NK 
cell is inhibited preventing damage to unblemished cells (2). The KIR2DL5 gene 
exists in two variants, KIR2DL5A and KIR2DL5B, they show 99.5- 99.7% coding 
sequence identity and are present at the telomeric half and the centromeric half of the 
KIR-gene cluster respectively (3).  
Described here is the identification of a novel KIR2DL5A subtype officially 
named KIR2DL5A*001:01:04 by the World Health Organisation (WHO) Committee 
for factors of the HLA System, Subcommittee for Killer-cell Immunoglobulin-like 
Receptors. This new allele was isolated from the DNA of Zimbabwean donors using 
previously described high-resolution long-range sequencing techniques (4). 
Full-length nucleotide sequences of KIR2DL5A*001:01:04 were compared to 
the allele KIR2DL5A*001:01:01 and we found 8 intronic single nucleotide 
polymorphisms four of which occurred in intron 2 as illustrated in Table 1. The 
nucleotide sequences of KIR2DL5*001:01:04 have been deposited into GenBank 





Table 1. Nucleotide sequences comparison between KIR2DL5A*001:01:01 and 
KIR2DL5A*001:01:04 
                                        Chromosomal positions                     
   636 638 904 1290 1293 1334 4161 6793 
2DL5A*001:01:01   A C T G C T A C 
2DL5A*001:01:04 G T A A T G del A 
Location  Int 1 Int 1 Int 2 Int 2 Int 2 Int 2 Int 4 Int 5 
Int: Intron 
 
The name 2DL5*001:01:04 has been officially assigned by the WHO 
Nomenclature Committee in October 2019. This follows the agreed policy that, 
subject to the conditions stated in the most recent Nomenclature Report (5), names 
will be assigned to new sequences as they are identified. Lists of such new names will 
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